Similar Articles |
|
American Family Physician October 1, 2000 Sarah Morgan & Lori Parry |
Quantum Sufficit A family dinner is healthier... coronary artery bypass graft better late than never... Is Alzheimer's disease inevitable?... Sex may cure hiccups... It's never too early to begin watching your child's weight... Vitamin E has benefits beyond being good for your skin... |
Nurse Practitioner May 2010 Townsend-Roccichelli et al. |
Managing sleep disorders in the elderly This article will provide an overview of sleep physiology in the aging population, identify common sleep disorders, and suggest pharmacologic and nonpharmacologic treatment options. |
Nurse Practitioner April 2012 Chaney & Sheriff |
Evidence-based treatments for smoking cessation Smoking addiction is both physical and mental. The etiology of tobacco dependence is multidimensional and includes physiological, psychological, and social/behavioral factors. |
Chemistry World July 3, 2014 Maria Burke |
Renewed focus on dementia checked by drug challenges The risks and barriers for companies working in dementia are huge, but so too, potentially, are the rewards, says Simon Ridley, head of research at Alzheimer's Research UK. |
The Motley Fool August 17, 2010 Brian Orelli |
Forget About This Drug Saving the Company Lilly's Alzheimer's drug fails hard. |
The Motley Fool January 19, 2011 Brian Orelli |
High Stakes at Tomorrow's FDA Panel Meeting It's more than just Eli Lilly on the line. |
Nursing June 2010 Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
BusinessWeek July 18, 2005 |
A Coronary Conundrum Four medical experts weigh in on whether heart surgery prolongs patients' lives or only relieves suffering. |
Nursing March 2012 Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Nursing June 2011 Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nursing February 2009 Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
The Motley Fool June 6, 2011 Luke Timmerman |
Exelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients Is Exelixis' risky bet about to pay off? |
Nurse Practitioner January 2012 Hedges & Ruggiero |
Treatment Options for Insomnia Nurse practitioners must be prepared to screen patients for this common sleep disorder as well as understand the latest treatment options for optimal patient outcomes. |
BusinessWeek July 15, 2010 Lopatto & Matsuyama |
The Race for Diagnostic Tests for Alzheimer's GE, Bayer, and Avid are vying to be first to market an early test for Alzheimer's. |
Nursing March 2010 Peg Gray-Vickrey |
Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice. |
American Journal of Nursing August 2011 Craft & Prahlow |
From Fecal Impaction to Colon Perforation The authors present the case of an elderly, nonverbal nursing home resident with dementia who developed fecal impaction, despite interventions such as enema. |
Nurse Practitioner August 2011 Davis et al. |
Supportive approaches for Alzheimer Disease Alzheimer disease accounts for almost 80% of all dementia diagnoses. Currently, more than 5 million Americans suffer from this debilitating illness, with the highest prevalence in the oldest age groups. |
Nurse Practitioner August 2009 Fisher & Valente |
Evaluating and managing insomnia Insomnia is the most frequent complaint in sleep disorders, and in the past, it had been viewed as a transient problem related only to other medical issues. That line of thought has changed |
Chemistry World October 8, 2010 Sarah Houlton |
U-turn on Alzheimer's drugs in the UK The UK National Institute for Health and Clinical Excellence proposes that those with mild disease will be able to receive them from early next year, on the basis of growing clinical evidence of their effectiveness. |
BusinessWeek June 9, 2009 John Carey |
Giving Patients the Data They Need A growing effort by doctors, insurers, and politicians helps people make better-informed medical decisions |
AskMen.com Jacob Franek |
Sleep Disorders Sleep disorders affect millions of people. Here's the lowdown on some of the more common sleep disorders and suggested remedies, so you can rest a little easier. |
Nursing March 2009 Kate J. Morse |
Focusing on the Surgical Patient with Cardiac Problems Learn about the latest guidelines for assessing cardiac risk and protecting his heart during noncardiac surgery. |
Pharmaceutical Executive December 1, 2010 Walter Armstrong |
Alzheimer's: A Disease at a Crossroads The need for new drugs intensifies as more and more Baby Boomers live into advanced old age. The global market is estimated to be worth $20 billion by the end of the decade. |
Pharmaceutical Executive December 1, 2010 Walter Armstrong |
The Next Wave: Pharm Exec's 2011 Pipeline Report 42 of the best new drugs in development or parked at the FDA |
BusinessWeek January 8, 2007 Catherine Arnst |
Decoding Alzheimer's After a century, promising treatments at last - and whispers of a cure. |
AskMen.com Dustin Driver |
Sleeping Pills You have a lot of options when it comes to sleeping pills. Take a look at this list of some of the most commonly prescribed sleeping pills before you make any decisions. |
The Motley Fool March 25, 2011 Brian Orelli |
Pfile Pfizer Under "Potential" Researchers reported promising finding from a clinical trial of Pfizer's new drug, CP-870,893, in pancreatic cancer patients in the most recent issue of the journal Science. |
BusinessWeek November 12, 2009 Catherine Arnst |
10 Ways to Cut Health-Care Costs Right Now Employers and hospitals don't have to wait for Congress to address inefficiencies and waste. |
Pharmaceutical Executive June 1, 2014 Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
American Family Physician August 15, 2003 Evans et al. |
Quantum Sufficit Impatience and a feeling of time urgency may increase young persons' risk of developing high blood pressure later in life... Prescription drug abuse among young people is on the rise... Learning to read forces the brain to do something it doesn't really want to do... etc. |
The Motley Fool June 10, 2011 Brian Orelli |
Abbott Picks Pumps Over Pills Treat Parkinson's disease, medical-device style. |
The Motley Fool January 29, 2010 Brian Orelli |
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. |
American Family Physician December 15, 2005 Meredith Desmond |
Quantum Sufficit - Just Enough Does having a better education help you sleep at night?... If it seems that men just aren't listening, there could be a physical explanation... Exercise in middle age may be the key to fighting Alzheimer's disease... etc. |
AskMen.com Kristen Armstrong |
Insomnia Causes And Treatments Insomnia can wreak havoc on a person's life. Sufferers can try meditation, exercise or relaxation methods to alleviate symptoms and enjoy long, restful sleep on a nightly basis. |
Pharmaceutical Executive November 1, 2012 Lauri Mitchell |
Who Pays for Specialty Medicines? Providers and patients fish for that delicate balance between access and abandonment. |
Chemistry World October 14, 2009 Phil Taylor |
Tracing amyloid in Alzheimer's A diagnostic compound that allows researchers to look into the brains of Alzheimer's patients will be used for the first time to gauge the effects of an experimental therapy for the disease. |
The Motley Fool August 10, 2010 Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
The Motley Fool September 7, 2010 Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
Pharmaceutical Executive May 1, 2009 Maryann Kuzel |
Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market. |
Chemistry World July 22, 2009 Phil Taylor |
New drug turns Alzheimer's theory on its head Researchers have been left puzzled by data showing that the antihistamine dimebolin, a drug with promising activity in improving Alzheimer's symptoms, actually seems to increase levels of the toxic protein beta amyloid. |
Pharmaceutical Executive November 1, 2012 Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Nursing January 2009 Susan Gallagher Camden |
Shedding Health Risks with Bariatric Weight Loss Surgery More obese patients are turning to bariatric weight loss surgery, which is proving its worth by decreasing or eliminating dangerous comorbidities of obesity. Here's how to help prepare your patient for surgery and care for her afterward. |
American Family Physician August 15, 2006 Sherri Damlo |
Quantum Sufficit - Just Enough Supersizing a fast-food combo meal can add inches to your waistline and make your wallet a whole lot leaner... Handing over the car keys may put older adults at higher risk of entering long-term care facilities... etc. |
Chemistry World June 14, 2012 Andrew Turley |
Good signs for Merck & Co insomnia pill In Phase III trials, insomnia drug candidate suvorexant performed well, reducing the time patients needed to fall asleep and increasing the total time sleeping, with some patients benefitting from the very first night of treatment. |